Charlotte's Web Holdings (CWBHF) Liabilities and Shareholders Equity (2020 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Liabilities and Shareholders Equity of $70.7 million for Q1 2026, down 34.56% year-over-year from $108.0 million in Q1 2025, and down 6.09% quarter-over-quarter from $75.3 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $70.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 34.56% year-over-year to $70.7 million; the TTM figure through Mar 2026 stood at $315.5 million (down 32.99% YoY), while the FY2025 annual figure was $75.3 million, down 33.65% from the prior year.
- Liabilities and Shareholders Equity slipped to $70.7 million in Q1 2026 per CWBHF's latest filing, from $75.3 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $187.6 million in Q4 2022 and bottomed at $70.7 million in Q1 2026.
- Historically, Liabilities and Shareholders Equity has averaged $131.7 million across 5 years, with a median of $140.5 million in 2022.
- Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity climbed 16.62% — and 2026, when it slumped 34.56%.
- Charlotte's Web Holdings' Liabilities and Shareholders Equity stood at $187.6 million in 2022, then fell by 18.7% to $152.5 million in 2023, then retreated by 25.64% to $113.4 million in 2024, then tumbled by 33.65% to $75.3 million in 2025, then slipped by 6.09% to $70.7 million in 2026.
- Business Quant data shows CWBHF's Liabilities and Shareholders Equity at $70.7 million in Q1 2026, $75.3 million in Q4 2025, and $81.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 6.18 Bn |
| 10 | Charlotte's Web Holdings | 63.18 Mn | 49.19 Mn | 5.16 Mn | 76.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 76.39 Mn |
| Mar 31, 2026 | 70.69 Mn |
| Dec 31, 2025 | 75.27 Mn |
| Sep 30, 2025 | 81.60 Mn |
| Jun 30, 2025 | 87.98 Mn |
| Mar 31, 2025 | 108.02 Mn |
| Dec 31, 2024 | 113.44 Mn |
| Sep 30, 2024 | 119.64 Mn |
| Jun 30, 2024 | 129.79 Mn |
| Mar 31, 2024 | 141.78 Mn |
| Dec 31, 2023 | 152.55 Mn |
| Sep 30, 2023 | 163.87 Mn |
| Jun 30, 2023 | 176.59 Mn |
| Mar 31, 2023 | 175.97 Mn |
| Dec 31, 2022 | 187.64 Mn |
| Sep 30, 2022 | 140.52 Mn |
| Jun 30, 2022 | 153.01 Mn |
| Mar 31, 2022 | 160.82 Mn |
| Dec 31, 2021 | 171.51 Mn |
| Dec 31, 2020 | 310.79 Mn |